MULTI EXPRESS DEFENDER VONCERT - ELI LILLY & CO/BAYER/NOVO-NORDISK B/PFIZER INC MULTI EXPRESS DEFENDER VONCERT - ELI LILLY & CO/BAYER/NOVO-NORDISK B/PFIZER INC Share Price
Certificat
F43058
DE000VM75109
| Real-time Borsa Italiana 06:34:29 02/07/2024 pm IST | ||
| 89.75 EUR | -0.50% |
|
| Current month | -0.88% | ||
| 1 month | -1.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 02/24/02 | 89.75 | -0.50% |
| 01/24/01 | 90.2 | -0.88% |
| 28/24/28 | 91 | +1.00% |
| 27/24/27 | 90.1 | 0.00% |
| 26/24/26 | 90.1 | -0.55% |
Real-time Borsa Italiana
Last update July 02, 2024 at 06:34 pm IST
More quotesStatic data
| Product type | Certificati Altri |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Vontobel
|
| F43058 | |
| ISIN | DE000VM75109 |
| Date issued | 10/01/2024 |
| Maturity | 08/01/2027 (920 Days) |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 99.3 € |
|---|---|
| Lowest since issue | 83.35 € |
| Spread | 1 € |
| Spread % | 1.10% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.4
USD
Average target price
868.9
USD
Spread / Average Target
-4.97%
- Stock Market
- Certificates
- F43058 Certificat
